Drug Safety

The Food and Drug Administration (FDA) is charged with ensuring the safety of drugs in the U.S.  The FDA plays the important role of approving drugs based on the results of clinical trials as well as monitoring and gathering data to ensure to determine if any adverse drugs reactions have become apparent after the drugs enter the marketplace.  The FDA developed MedWatch to provide important safety information to consumers and to allow consumers to report serious problems with human medical products.  For the best outcomes, consumers must be informed about this MedWatch system so that they can learn important safety information on the drugs that they take and how to report adverse reactions to prescription drugs.  As part of the passage of the Food and Drug Safety Act of 2007, I worked to include a requirement that will improve consumers’ awareness of the MedWatch Program.  My amendment, which was incorporated into the law, requires that printed prescription drug ads include  information on how to report side effects to the FDA’s MedWatch program both on the internet and through a toll-free number.  The FDA was also required to study how we can best include this important information in TV ads for prescription medications.

Resources

FDA Drug Safety and Availability

More on Drug Safety

March 1, 2021 Page

H.R. 1319, The American Rescue Plan Act of 2021
An Urgently-Needed Package to Address The Coronavirus Health & Economic Crisis    

Passed House of Representatives February 27, 2021

Amended and Passed by the Senate on March 6, 2021

February 27, 2021 Press Release

WASHINGTON - Today, Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip and a senior member of the House Budget Committee, released the following statement after the House of Representatives passed H.R. 1319, President Biden’s American Rescue Plan Act, by a vote of 219-210:

February 5, 2021 Press Release

WASHINGTON - Today, Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip and Chair of the Consumer Protection and Commerce Subcommittee, announced the introduction of a package of legislation to address serious problems that have emerged during the COVID-19 crisis.

January 28, 2021 Press Release

EVANSTON - Today, Congresswoman Jan Schakowsky (D-IL), a Senior Chief Deputy Whip and Chair of the Energy and Commerce Consumer Protection and Commerce Subcommittee; Congressman Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee; Congresswoman Rosa DeLauro (D-CT), Chair of the House Appropriations Committee; and, Congressman Peter DeFazio (D-OR), Chair of the Transportation and Infrastructure Committee reintroduced legislation to strengthen oversight of federal funds invested in COVID-19 research and development, and to protect patients from being price-gouged on CO

January 18, 2021 Press Release

EVANSTON – Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip, released the following statement on her reappointment as Chairwoman of the House Committee on Energy and Commerce’s Consumer Protection and Commerce Subcommittee:

“I’m honored to have been selected by my colleagues to serve a second term as chair the Consumer Protection and Commerce Subcommittee. Consumer protection is what drew me to public life, and I will continue to focus on the safety of products our families, especially our children, use every day.

Pages